ABBV vs CROX · P/E 81, rev $61.16B vs rev $4.10B
AbbVie Inc (ABBV) versus Crocs Inc (CROX) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
Crocs Inc (CROX) is a footwear & accessories company listed on US.
Latest reported ABBV revenue for 2025-12-31 was $61.16B. Net income was $4.23B. Revenue was up 305.0% from 2024-12-31 to 2025-12-31. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported CROX revenue for 2024-12-31 was $4.10B. Net income was $950.1M. Revenue was up 3.5% from 2023-12-31 to 2024-12-31. CROX currently screens at market cap $5.93B.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. CROX currently screens at market cap $5.93B.
Not investment advice. Open the ABBV and CROX stock pages for the full models.
Not investment advice.